[可切除）胰腺癌新辅助治疗和辅助治疗的未来概念]。

4区医学 Q3 Medicine Chirurg Pub Date : 2022-05-01 Epub Date: 2022-04-04 DOI:10.1007/s00104-022-01623-w

Thomas Seufferlein, Christoph Michalski

{"title":"[可切除）胰腺癌新辅助治疗和辅助治疗的未来概念]。","authors":"Thomas Seufferlein, Christoph Michalski","doi":"10.1007/s00104-022-01623-w","DOIUrl":null,"url":null,"abstract":"Pancreatic cancer still has a very unfavorable prognosis. This is true even for the comparably small group of patients (maximum 15%) who are diagnosed with a clearly resectable tumor. The article provides information on the current statements of the S3 guidelines on adjuvant and neoadjuvant treatment of resectable pancreatic cancer and describes adjuvant and neoadjuvant treatment strategies. Furthermore, the article pursues the questions of if and for whom a total neoadjuvant treatment is suitable and which options of a personalized treatment are available for resectable pancreatic cancer.","PeriodicalId":50700,"journal":{"name":"Chirurg","volume":"93 1","pages":"441-445"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"[Future concepts for neoadjuvant and adjuvant treatment of (resectable) pancreatic cancer].\",\"authors\":\"Thomas Seufferlein, Christoph Michalski\",\"doi\":\"10.1007/s00104-022-01623-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Pancreatic cancer still has a very unfavorable prognosis. This is true even for the comparably small group of patients (maximum 15%) who are diagnosed with a clearly resectable tumor. The article provides information on the current statements of the S3 guidelines on adjuvant and neoadjuvant treatment of resectable pancreatic cancer and describes adjuvant and neoadjuvant treatment strategies. Furthermore, the article pursues the questions of if and for whom a total neoadjuvant treatment is suitable and which options of a personalized treatment are available for resectable pancreatic cancer.\",\"PeriodicalId\":50700,\"journal\":{\"name\":\"Chirurg\",\"volume\":\"93 1\",\"pages\":\"441-445\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chirurg\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00104-022-01623-w\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/4/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chirurg","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00104-022-01623-w","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/4/4 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 1

摘要

胰腺癌的预后仍然很差。即使是对少数（最多 15%）确诊为可明确切除肿瘤的患者来说，情况也是如此。文章介绍了目前S3指南中关于可切除胰腺癌辅助治疗和新辅助治疗的声明，并介绍了辅助治疗和新辅助治疗策略。此外，文章还探讨了新辅助治疗是否适用于哪些患者以及哪些个性化治疗方案适用于可切除胰腺癌等问题。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

[Future concepts for neoadjuvant and adjuvant treatment of (resectable) pancreatic cancer].

Pancreatic cancer still has a very unfavorable prognosis. This is true even for the comparably small group of patients (maximum 15%) who are diagnosed with a clearly resectable tumor. The article provides information on the current statements of the S3 guidelines on adjuvant and neoadjuvant treatment of resectable pancreatic cancer and describes adjuvant and neoadjuvant treatment strategies. Furthermore, the article pursues the questions of if and for whom a total neoadjuvant treatment is suitable and which options of a personalized treatment are available for resectable pancreatic cancer.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Chirurg 医学-外科

CiteScore

1.10

自引率

0.00%

发文量

审稿时长

4-8 weeks

期刊介绍： Der Chirurg; Zeitschrift fur Alle Gebiete der Operativen Medizen The magazine is intended for surgeons in hospitals, clinics and research. Each issue includes a comprehensive theme: Practical summaries access to selected topics and provide the reader with a compilation of current knowledge in all fields of surgery. Besides imparting relevant background knowledge, the emphasis is on the review of scientific results and practical experience. The reader will find concrete recommendations.